Skip to main content

5 articles related to "Trilaciclib"

No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.

Articles

Case Report

Published on 22 Oct 2025

Case Report: Analysis of short-term clinical efficacy of trilaciclib in patients with advanced lung neuroendocrine carcinoma undergoing chemotherapy

in Thoracic Oncology

Yan Zeng
Nan Lin

Frontiers in Oncology

doi 10.3389/fonc.2025.1685910

1,568 views

Systematic Review

Published on 25 May 2023

The efficacy and safety of Trilaciclib in preventing chemotherapy-induced myelosuppression: a systematic review and meta-analysis of randomized controlled trials

in Pharmacology of Anti-Cancer Drugs

Jingyue Qiu
Dandan Sheng
Fei Lin
Peng Jiang
Ning Shi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1157251

8,300 views
14 citations

Review

Published on 08 Jul 2021

Improving Outcomes of Chemotherapy: Established and Novel Options for Myeloprotection in the COVID-19 Era

in Cancer Molecular Targets and Therapeutics

Gary H. Lyman
Nicole M. Kuderer
Matti Aapro

Frontiers in Oncology

doi 10.3389/fonc.2021.697908

10,711 views
21 citations

Case Report

Published on 22 Apr 2024

Myelopreservation with Trilaciclib in recurrent advanced ovarian cancer: a case report

in Gynecological Oncology

Huaming Tan
Xiuchen Han
Chao Li
Wenli Liu
Kanghong Li
Xiugui Sheng
Shuying Qi

Frontiers in Oncology

doi 10.3389/fonc.2024.1343239

2,243 views
1 citation

Systematic Review

Published on 08 Apr 2026

Trilaciclib for prophylaxis of chemotherapy-induced myelosuppression in solid tumor patients: a systematic review and meta-analysis

in Pharmacology of Anti-Cancer Drugs

Ting Yang
Pengjie Yang
Danyang Meng
Yong Zhu
Benben Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2026.1754502

471 views